Costs of medication use among patients with juvenile idiopathic arthritis in the Dutch healthcare system
Michelle MA Kip, Sytze de Roock, Gillian Currie, Deborah A Marshall, Luiza R Grazziotin, Marinka Twilt, Rae SM Yeung, Susanne M Benseler, Maud A Schreijer, Sebastiaan J Vastert, Nico Wulffraat, Annet van Royen-Kerkhof, Joost F Swart, Maarten J IJzerman
Expert Review of Pharmacoeconomics & Outcomes Research | TAYLOR & FRANCIS LTD | Published : 2020
Background: This study aims to quantify medication costs in juvenile idiopathic arthritis (JIA), based on subtype.Research design and methods: This study is a single-center, retrospective analysis of prospective data from electronic medical records of JIA patients, aged 0-18 years between 1 April 2011 and 31 March 2019. Patient characteristics (age, gender, subtype) and medication use were extracted. Medication use and costs were reported as: 1) mean total annual costs; 2) between-patient heterogeneity in these costs; 3) duration of medication use; and, 4) costs over the treatment course.Results: The analysis included 691 patients. Mean total medication costs were €2,103/patient/year, includ..View full abstract
Awarded by Canadian Institutes of Health Research (Canada)
This work was supported by the Canadian Institutes of Health Research (Canada) [grant number 381280]; Genome Canada (Canada); ZonMW (the Netherlands); and the Reumafonds (the Netherlands).